Skip to main content

Abstract

This study is aimed at developing a ligand to be used for imaging estrogen receptor positive breast tumors by Positron Emission Tomography (PET). We describe the synthesis of fluorotamoxifen analogs with the fluorine atom positioned on the aliphatic side chain of tamoxifen and the measurement of the in vitro binding of fluorotamoxifens to estrogen receptors. N,N-Diethylfluorotamoxifen was prepared from the tosyl ester of the corresponding hydroxy derivative. 18F-Labeled N,N-diethylfluoromethyltamoxifen was prepared in 60% yield. These studies indicate that fluorinated tamoxifens have high affinity for estrogen receptors and can be labeled with 18F, thus reflecting a potential for use in imaging estrogen receptors by PET.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J.L. Wittliff. Steroid-hormone receptors in breast cancer, Cancer Res. 53: 630 (1984).

    CAS  Google Scholar 

  2. W.L. McGuire, K.B. Horowitz, O.H. Pearson and A. Segaloff. Current status of estrogen and progesterone receptors in breast cancer, Cancer 39: 2934 (1977).

    CAS  Google Scholar 

  3. M.D. Fernandez, J.I. Burn, P.D. Sauven, G. Parmar, J.O. White and L. Myatt. Activated estrogen receptors in breast cancer and response to endocrine therapy, Eur. J. Cancer Clin. Oncol. 20: 41 (1984).

    Article  PubMed  CAS  Google Scholar 

  4. M.A. Mintun, M.J. Welch, B.A. Siegel, C.J. Mathias, J.W. Brodack, A.H. McGuire and J.A. Katzenellenbogen. Breast cancer: PET imaging of estrogen receptors, Radiology 169: 45 (1988).

    CAS  Google Scholar 

  5. K. Hamacher, H.H. Coenen, G. Stöcklin. Efficient sterospecific synthesis of no-carrier-added 1-18Ffluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution, J. Nucl. Med. 27(2):235 (1986).

    Google Scholar 

  6. A.B. Foster, R. McCague, A. Seago, G. Leclercq, S. Stoessel and F. Roy. Modification of the basic side chain in tamoxifen: effects on microsomal metabolism and in vitro biological activity, Anticancer Drug Design. 1: 245 (1986).

    CAS  Google Scholar 

  7. W.C. Still, M. Kahn and A. Mitra. Rapid chromatographic technique for preparative separations with moderate resolution, J. Org. Chem. 43, 2923 (1978).

    Google Scholar 

  8. A.B. Foster, M. Jarman, 0-T Leung, R. McCague, G. Leclercq and N-Devleeschouwer. Hydroxy derivatives of tamoxifen, J. Med. Chem. 28:1491 (1985).

    Google Scholar 

  9. J.H. Fishman. Stabilization of estradiol-receptor complexes by elimination of cytosolic factors, Biochem. Biophys. Res. Commun. 110:713 (1983).

    Google Scholar 

  10. R. McCague, G. Leclercq and V.C. Jordan Nonisomerizable analogs of (Z) and (E)-4-hydroxytamoxifen. Synthesis and endocrinological properties of substituted diphenylbenzocycloheptenes, J. Med. Chem. 31:1285 (1988).

    Google Scholar 

  11. O.H. Lowry, N.J. Rosebrough. A.L. Farr, and R.J. Randall. Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193: 265 (1951).

    PubMed  CAS  Google Scholar 

  12. T. Mosmann, Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays, J. Immunol. Methods 65:55 (1983).

    Google Scholar 

  13. J. Shani, A. Gazit, T. Livshitz and S. Biran. Synthesis and receptor binding affinity of fluorotamoxifen, a possible estrogen-receptor imaging agent, J. Med. Chem. 28:1504, 1985.

    Google Scholar 

  14. R. McCague and G. Leclercq. Synthesis, conformational considerations and estrogen receptor binding of 1-[42-dimethylaminoethoxyphenyl]-1,2-diphenylbutane, J. Med. Chem. 30:1761, 1987.

    Google Scholar 

  15. B.S. Katzenellenbogen, M.J. Norman, R.L. Eckert, S.W. Peitz and W.F. Mangel. Bioactivities, estrogen receptor interactions and plasminogen activator-inducing activities of tamoxifen and hydroxytamoxifen isomers in MCF-7 human breast cancer cells, Cancer Res. 44, 112, 1984.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Yang, D.J. et al. (1991). Potential Breast Tumor Imaging Agents: Fluorotamoxifen and Derivatives. In: Emran, A.M. (eds) New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0626-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0626-7_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0628-1

  • Online ISBN: 978-1-4899-0626-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics